UNC13B and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, UNC13B may directly or indirectly promote the biological activities of ATO-resistant CML cells by affecting the abovementioned proteins, the underlying mechanism may involve mitochondrial quality control.